Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McGill University

$248,463.00

Downstream effectors of LKB1 mediated tumour suppression

FY 2015-16

Summary
Mutations in a gene called LKB1 have been found to give rise to a cancer predisposing syndrome called Peutz Jeghers Syndrome. These patients have a high incidence of various types of tumours and it is linked to losing a single copy of the LKB1 gene-it is therefore considered to be a dominant disease. It is not clear why two copies of this gene are absolutely necessary but together they function to block tumour growth-when disabled tumours will form. LKB1 is an essential gene so it is difficult to look at mutations in many animal models but in C. elegans we have mutations that survive and give rise to a multitude of defects. We propose to use this extraordinary genetic model to better understand how LKB1 carries out its ability to block tumour growth so that we may find specific targets that we can use to develop drugs to combat the growth of tumours that occur when LKB1 is mutated.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
344424
Name
Roy Richard D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Downstream effectors of LKB1 mediated tumour suppression
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$248,463
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Ampk; C. Elegans; Cancer; Germline Stem Cells; Lkb1; Notch; Peutz Jeghers Syndrome; Quiescence; Tor Signalling; Tumour Suppressor
Abstract
Mutations in a gene called LKB1 have been found to give rise to a cancer predisposing syndrome called Peutz Jeghers Syndrome. These patients have a high incidence of various types of tumours and it is linked to losing a single copy of the LKB1 gene-it is therefore considered to be a dominant disease. It is not clear why two copies of this gene are absolutely necessary but together they function to block tumour growth-when disabled tumours will form. LKB1 is an essential gene so it is difficult to look at mutations in many animal models but in C. elegans we have mutations that survive and give rise to a multitude of defects. We propose to use this extraordinary genetic model to better understand how LKB1 carries out its ability to block tumour growth so that we may find specific targets that we can use to develop drugs to combat the growth of tumours that occur when LKB1 is mutated.
Competitiondate
201603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Roy, Richard D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $248,463~ $0~
McGill University - $248,463 Grant (2015-16) | Canada Spends